The DOI matches its Crossref record; 302 of the 305 references it cites were found in a registry or an index.
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Open accessAbstract
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In contrast with the 2009 Infectious Disease Society of America guidelines for the treatment of invasive candidiasis, in which echinocandins were recommended only for neutropenic patients and patients with previous exposure to antifungals (64)”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [64]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Consensus guidelines do suggest a combination of amphotericin B and flucytosine for some infection types such as Candida meningitis, endophthalmitis, and endocarditis.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“The IDSA guideline for invasive candidiasis recommends a 2-week treatment duration following clearance of Candida from the bloodstream and resolution of symptoms attributable to candidemia.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Longer durations are recommended for persistent candidemia and for metastatic infection involving other sites (ie, CNS, bone, endocarditis, joint/ prosthetic joint infection).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Treatment guidelines recommend step down to fluconazole for patients who have improved clinically after initial therapy with an echinocandin or amphotericin B and who are infected with an organism that is likely to be susceptible to fluconazole (eg, C albicans, C parapsilosis, and C tropicalis) or if there is documented susceptibility based on laboratory MIC testing.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Therefore, the current guidelines suggest ophthalmologic examination for every patient with candidemia.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Venous catheter infection and IC guidelines, including the current IDSA guidelines, recommend removal of any intravascular catheter that is positive for a fungal pathogen (ie, Candida) based on evidence from large retrospective and observational studies.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [110]
In the citing paper
“Thus, the American Society of Infectious Diseases recommends that patients should use topical and oral azoles concurrently [38].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [38]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [6]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“krusei [26, 81], but”
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Self-citationGarey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Self-citationRex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Self-citationWalsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citationWalsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Self-citationAnidulafungin versus Fluconazole for Invasive Candidiasis
Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894
Self-citationPascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887
Self-citationPizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W. G., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 837
Self-citationInstitute of Medicine (1990) · National Academies Press eBooks · doi:10.17226/1626 · Cited by 807
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
Self-citationvan Burik, J. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 741
Self-citationCaillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C. M., Cuisenier, B., Solary, É., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 700
Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
Sobel, J. D., Faro, S., Force, R. W., Foxman, B., Ledger, W. J., Nyirjesy, P., Reed, B. D., & Summers, P. R. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80001-x · Cited by 694
Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692
Self-citationOstrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
Self-citationBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661
Self-citationTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Self-citationBenjamin, D. K., Stoll, B. J., Fanaroff, A., McDonald, S. A., Oh, W., Higgins, R. D., Duara, S., Poole, W. K., Laptook, A. R., & Goldberg, R. N. (2006) · PEDIATRICS · doi:10.1542/peds.2004-2292 · Cited by 659
Self-citationLeón, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659
Odabaşı, Z., Mattiuzzi, G. N., Estey, E., Kantarjian, H. M., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M., Rex, J. H., & Ostrosky‐Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 641
Self-citationMicafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638
Self-citationWalsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A. C., Bow, E. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 623
Self-citationViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Maertens, J. A., Theunissen, K., Verhoef, G. E. G., Verschakelen, J., Lagrou, K., Verbeken, E. K., Wilmer, A., Verhaegen, J., Boogaerts, M. A., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 589
Caillot, D., Couaillier, J.-F., Bernard, A., Casasnovas, O., Denning, D. W., Mannone, L., López, J. B., Couillault, G., Piard, F., Vagner, O., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.253 · Cited by 582
Catheter-Associated Urinary Tract Infection Is Rarely Symptomatic
Tambyah, P. A., & Maki, D. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.678 · Cited by 537
Wingard, J. R., White, M. H., Anaissie, E. J., Raffalli, J. T., Goodman, J., Arrieta, A. C., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 524
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523
Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521
Self-citationMaertens, J. A., Verhaegen, J., Lagrou, K., Eldere, J. V., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Fungal Endocarditis: Evidence in the World Literature, 1965-1995
Ellis, M. E., Al-Abdely, H., Sandridge, A., Greer, W., & Ventura, W. (2001) · Clinical Infectious Diseases · doi:10.1086/317550 · Cited by 505
Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Self-citationMarr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493
The Periodic Health Examination
Frappier-Davignon, L. (1934) · New England Journal of Medicine · doi:10.1056/nejm193401252100413 · Cited by 488
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033114 · Cited by 487
Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients
Kauffman, C. A., Vazquez, J. A., Sobel, J. D., Gallis, H. A., McKinsey, D. S., Karchmer, A. W., Sugar, A. M., Sharkey, P. K., Wise, G. J., Mangi, R., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313583 · Cited by 483
Self-citationEpidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478
Self-citationMortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451
Sobel, J. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712253372607 · Cited by 446
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437
Revisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
Eggimann, P., Francioli, P., Bille, J., Schneider, R., Wu, M.-M., Chapuis, G., Chiolero, R., Pannatier, A., Schilling, J., Geroulanos, S., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199906000-00019 · Cited by 414
Self-citationEmpiric antifungal therapy in febrile granulocytopenic patients
Meunier, F. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90441-5 · Cited by 407
Deray, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.37 · Cited by 401
Voriconazole therapeutic drug monitoring
Smith, J., Safdar, N., Knasinski, V., Simmons, W., Bhavnani, S. M., Ambrose, P. G., & Andes, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1570-1572.2006 · Cited by 399
Self-citationHepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
Thaler, M., PASTAKIA, B., SHAWKER, T. H., O’Leary, T. J., & Pizzo, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 394
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Self-citationGroll, A. H., Giri, N., Petraitis, V., Petraitienė, R., Candelario, M., Bacher, J., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Self-citationOstrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Self-citationRisk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates
Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065733 · Cited by 355
Walsh, T. J., Karlsson, M. O., Driscoll, T., Arguedas, A. G., Adamson, P. C., Sáez‐Llorens, X., Vora, A. J., Arrieta, A. C., Blumer, J. L., Lutsar, I., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2166-2172.2004 · Cited by 339
Self-citationAlly, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P., Romero, A. J., & the Esophageal Candidiasis Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/322653 · Cited by 331
Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N., & Kauffman, C. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90300-x · Cited by 322
Self-citationBoogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321
Self-citationPelz, R. K., Hendrix, C. W., Swoboda, S. M., Diener‐West, M., Merz, W. G., Hammond, J., & Lipsett, P. A. (2001) · Annals of Surgery · doi:10.1097/00000658-200104000-00010 · Cited by 314
Hariprasad, S. M. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.1.42 · Cited by 312
Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308
Edwards, J. E., Foos, R. Y., Montgomerie, J. Z., & Guze, L. B. (1974) · Medicine · doi:10.1097/00005792-197401000-00002 · Cited by 303
Self-citationWhite, M. H., Bowden, R. A., Sandler, E. S., Graham, M. L., Noskin, G. A., Wingard, J. R., Goldman, M., van Burik, J., McCabe, A., Lin, J. S., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514672 · Cited by 303
Pfaller, M. A., Diekema, D. J., & Sheehan, D. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.435-447.2006 · Cited by 300
Courtney, R., Pai, S. M., Laughlin, M. A., Lim, J. M., & Batra, V. K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2788-2795.2003 · Cited by 298
Predictors of Adverse Outcome in Cancer Patients with Candidemia
Anaissie, E. J., Rex, J. H., Uzun, Ö., & Vartivarian, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00030-8 · Cited by 295
Self-citationSaravolatz, L. D., Deresinski, S. C., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/375080 · Cited by 295
Villanueva, A., Gotuzzo, E., Arathoon, E., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 290
Posaconazole: a broad-spectrum triazole antifungal
Torres, H. A., Hachem, R. Y., Chemaly, R. F., Kontoyiannis, D. P., & RAAD, I. I. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70297-8 · Cited by 287
The periodic health examination. Canadian Task Force on the Periodic Health Examination.
(1979) · PubMed Central · Cited by 281
EL-EBIARY, M., TORRES, A., FÁBREGAS, N., de la BELLACASA, J. P., GONZÁLEZ, J., RAMIREZ, J., del BAÑO, D., HERNÁNDEZ, C., & JIMÉNEZ de ANTA, M. T. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9612023 · Cited by 271
Empirical antifungal therapy in febrile granulocytopenic patients
Meunier, F. (1989) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 268
Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis
Essman, T. F., Flynn, H. W., Smiddy, W. E., Brod, R. D., Murray, T. G., Davis, J. L., & Rubsamen, P. E. (1997) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-19970301-03 · Cited by 264
Glasmacher, A. G., Prentice, A. G., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegović, B., & Schmidt‐Wolf, I. G. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.052 · Cited by 263
Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Billé, J., Calandra, T., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/527382 · Cited by 263
Self-citationLutsar, I., Roffey, S. J., & Troke, P. F. (2003) · Clinical Infectious Diseases · doi:10.1086/377131 · Cited by 263
Winston, D. J., Pakrasi, A., & Busuttil, R. W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-10-199911160-00003 · Cited by 261
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
Bow, E. J., Laverdière, M., Lussier, N., Rotstein, C., Cheang, M., & Ioannou, S. (2002) · Cancer · doi:10.1002/cncr.10610 · Cited by 257
Micafungin: A New Echinocandin
Chandrasekar, P. H., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/501020 · Cited by 255
Intravascular Catheter Exchange and Duration of Candidemia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., Serody, J., Edwards, J. E., Washburn, R. G., NIAID Mycoses Study Group, & Candidemia Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.4.994 · Cited by 252
Self-citationGarbino, J., Lew, D. P., Romand, J.-A., Hugonnet, S., Auckenthaler, R., & Pittet, D. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1540-y · Cited by 246
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis
Stamm, A. M., Diasio, R. B., Dismukes, W. E., Shadomy, S., Cloud, G. A., Bowles, C. A., Karam, G. H., & Espinel‐Ingroff, A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90691-7 · Cited by 243
Krause, D. S., Simjee, A. E., van Rensburg, C. E. J., Viljoen, J., Walsh, T. J., Goldstein, B. P., Wible, M., & Henkel, T. (2004) · Clinical Infectious Diseases · doi:10.1086/423378 · Cited by 241
Self-citationMoudgal, V. V., Little, T., Boikov, D. A., & Vázquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 241
Seibel, N. L., Schwartz, C. L., Arrieta, A. C., Flynn, P. M., Shad, A. T., Albano, E., Keirns, J. J., Lau, W. M., Facklam, D., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 241
Self-citationCLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
Calandra, T., Schneider, R., Billé, J., Mosimann, F., & Francioli, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92043-6 · Cited by 237
Self-citationCandiduria in critically ill patients admitted to intensive care medical units
Álvarez-Lerma, F., Nolla‐Salas, J., León, C., Palomar, M., Jordà, R., Carrasco, N., & Bobillo, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1807-y · Cited by 221
Candida infective endocarditis
Baddley, J. W., Benjamin, D. K., Patel, M., Miró, J. M., Athan, E., Baršić, B., Bouza, E., Clara, L., Elliott, T. S. J., Kanafani, Z. A., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0466-x · Cited by 217
Self-citationAnaissie, E. J., Bodey, G. P., Kantarjian, H. M., David, C. L., Barnett, K., Bow, E. J., DeFelice, R., Downs, N., File, T. M., Karam, G. A., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90006-j · Cited by 217
Piarroux, R., Grenouillet, F., Balvay, P., Tran, V., Blasco, G., Millon, L., & Boillot, A. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147726.62304.7f · Cited by 215
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial
Schuster, M. G., Edwards, J. E., Sobel, J. D., Darouiche, R. O., Karchmer, A. W., Hadley, S., Slotman, G., Panzer, H., Biswas, P., & Rex, J. H. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00004 · Cited by 210
Self-citationBenjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 209
Self-citationTreatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine
Sobel, J. D., Chaim, W., Nagappan, V., & Leaman, D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00726-9 · Cited by 206
Wet, N. T. E. D., Llanos‐Cuentas, A., Suleiman, J. M. A. H., Baraldi, E., Krantz, E., Negra, M. D., & Diekmann-Berndt, H. (2004) · Clinical Infectious Diseases · doi:10.1086/423377 · Cited by 203
Reviews Of Anti‐infective Agents: Anidulafungin: A Novel Echinocandin
Vázquez, J. A., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/505204 · Cited by 197
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin
Breit, S. M., Hariprasad, S. M., Mieler, W. F., Shah, G. K., Mills, M. D., & Grand, M. G. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.08.077 · Cited by 193
Hepatosplenic candidiasis: Successful treatment with fluconazole
Kauffman, C. A., Bradley, S., Ross, S. C., & Weber, D. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90005-i · Cited by 193
Self-citationBonacini, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.8.1567 · Cited by 190
Winston, D. J., Hathorn, J. W., Schuster, M. G., Schiller, G. J., & Territo, M. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00457-x · Cited by 189
The central nervous system and infection by Candida species
Sánchez-Portocarrero, J., Pérez-Cecilia, E., Corral, O. J., Romero-Vivas, J., & Picazo, J. J. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00140-1 · Cited by 189
Baley, J. E., Meyers, C., Kliegman, R. M., Jacobs, M. R., & Blumer, J. L. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82674-5 · Cited by 184
Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., Uzun, Ö., Pinczowski, H., Kontoyiannis, D. P., Khoury, P. N., Papadakis, K., Gardner, A., RAAD, I. I., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80072-6 · Cited by 184
The Periodic Health Examination: 1980
Delbanco, T. L., & TAYLOR, W. C. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-251 · Cited by 183
Obayashi, T., Negishi, K., Suzuki, T., & Funata, N. (2008) · Clinical Infectious Diseases · doi:10.1086/588295 · Cited by 183
Paphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Medical Mycology · doi:10.1080/13693780410001731619 · Cited by 179
Self-citationNosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
Luzzati, R., Amalfitano, G., Lazzarini, L., Soldani, F., Bellino, S., Solbiati, M., Danzi, M. C., Vento, S., Todeschini, G., Vivenza, C., et al. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000325 · Cited by 179
LIPOSOMAL AMPHOTERICIN B PREVENTS INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS
Tollemar, J. G., Höckerstedt, K., Ericzon, B., Jalanko, H., & Ringdén, O. T. H. (1995) · Transplantation · doi:10.1097/00007890-199501150-00009 · Cited by 179
Should central venous catheters be removed as soon as candidemia is detected in neonates
Karlowicz, M. G., Hashimoto, L. N., Kelly, R. E., & Buescher, E. S. (2000) · Pediatrics · doi:10.1542/peds.106.5.e63 · Cited by 178
Population Pharmacokinetics of Fluconazole in Young Infants
Wade, K. C., Wu, D., Kaufman, D. A., Ward, R. M., Benjamin, D. K., Sullivan, J. E., Ramey, N., Jayaraman, B., Hoppu, K., Adamson, P. C., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00569-08 · Cited by 178
Self-citationThe Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants
Heresi, G. P., Gerstmann, D. R., Reed, M. D., van den Anker, J. N., Blumer, J. L., Kovanda, L. L., Keirns, J. J., Buell, D. N., & Kearns, G. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000245103.07614.e1 · Cited by 178
Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 177
HADLEY, S., SAMORE, M. H., LEWIS, W. D., Jenkins, R. L., Karchmer, A. W., & Hammer, S. M. (1995) · Transplantation · doi:10.1097/00007890-199503000-00009 · Cited by 176
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
Peer, A. V., Woestenborghs, R., Heykants, J., Gasparini, R., & Gauwenbergh, G. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558308 · Cited by 176
Vázquez, J. A., Skiest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J. P., Greaves, W. L., & ISAACS, R. E. (2006) · Clinical Infectious Diseases · doi:10.1086/501457 · Cited by 171
The Changing Face of Fungal Infections in Health Care Settings
Weinstein, R. A., & Fridkin, S. K. (2005) · Clinical Infectious Diseases · doi:10.1086/497138 · Cited by 170
Arndt, C. A. S., Walsh, T. J., McCully, C. L., Balis, F. M., Pizzo, P. A., & Poplack, D. G. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.1.178 · Cited by 169
Self-citationAbruzzo, G. K., Gill, C., Flattery, A. M., Kong, L., Leighton, C., Smith, J. G., Pikounis, V. B., Bartizal, K. F., & Rosen, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2310-2318.2000 · Cited by 169
Driessen, M., Ellis, J. B., Cooper, P. A., Wainer, S., Muwazi, F., Hahn, D., Gous, H., & Villiers, F. P. R. D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199612000-00011 · Cited by 169
Mattiuzzi, G. N., Alvarado, G. C., Giles, F. J., Ostrosky‐Zeichner, L., Cortes, J. E., O'Brien, S. M., Verstovšek, S., Faderl, S. H., Zhou, X., RAAD, I. I., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.143-147.2006 · Cited by 168
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007) · Clinical Infectious Diseases · doi:10.1086/510677 · Cited by 168
Self-citationEndogenous Endophthalmitis Among Patients with Candidemia
Parke, D. W., Jones, D. B., & Gentry, L. O. (1982) · Ophthalmology · doi:10.1016/s0161-6420(82)34722-3 · Cited by 167
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*
Shorr, A. F., Chung, K., Jackson, W. L., Waterman, P. E., & Kollef, M. H. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178352.14703.49 · Cited by 167
Vertebral Osteomyelitis due toCandidaSpecies: Case Report and Literature Review
Miller, D. J., & Mejicano, G. C. (2001) · Clinical Infectious Diseases · doi:10.1086/322634 · Cited by 166
Pharmacokinetics of voriconazole and cytochrome p450 2C19 genetic status
Ikeda, Y. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.02.002 · Cited by 163
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
Smith, P. B., Walsh, T. J., Hope, W. W., Arrieta, A. C., Takada, A., Kovanda, L. L., Kearns, G. L., Kaufman, D. A., Sawamoto, T., Buell, D. N., et al. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181910e2d · Cited by 163
Self-citationSkiest, D. J., Vazquez, J. A., Anstead, G. M., Graybill, J. R., Reynes, J., Ward, D., Hare, R., Boparai, N., & Isaacs, R. (2007) · Clinical Infectious Diseases · doi:10.1086/511039 · Cited by 162
Grossi, P., Farina, C., FIOCCHI, R., & Gasperina, D. D. (2000) · PubMed · Cited by 162
Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
Leleu, G., Aegerter, P., & Guidet, B. (2002) · Journal of Critical Care · doi:10.1053/jcrc.2002.35815 · Cited by 161
Lumbreras, C., Cuervas‐Mons, V., Jara, P., del Palacio, A., Turrión, V. S., Barrios, C., Moreno, E., Noriega, A. R., & Paya, C. V. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.3.583 · Cited by 160
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki491 · Cited by 159
Combined Therapy with Amphotericin B and 5-Fluorocytosine for Candida Meningitis
Smego, R. A., Perfect, J. R., & Durack, D. T. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.6.791 · Cited by 159
Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole
Sobel, J. D., Kapernick, P. S., Zervos, M., Reed, B. D., Hooton, T., Soper, D., Nyirjesy, P., Heine, M. W., Willems, J., Panzer, H., et al. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.115116 · Cited by 158
Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis
Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157
The Role of Candida sp Isolated From Bronchoscopic Samples in Nonneutropenic Patients
Rello, J., Esandi, M.-E., Diaz, E., Mariscal, D., Gallego, M., & Vallès, J. (1998) · Chest · doi:10.1378/chest.114.1.146 · Cited by 155
Benedetti, E., Gruessner, A. C., Troppmann, C., Papalois, B. E., Sutherland, D. E. R., Dunn, D. L., & Gruessner, R. W. G. (1996) · PubMed · Cited by 154
Clinical pharmacokinetics of voriconazole
Levêque, D., Nivoix, Y., Jehl, F., & Herbrecht, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.003 · Cited by 148
Pulmonary disease caused by Candida species
Masur, H., Rosen, P. P., & Armstrong, D. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90546-0 · Cited by 146
McMullan, R., Metwally, L., Coyle, P. V., Hedderwick, S., McCloskey, B., O'Neill, H. J., Patterson, C. C., Thompson, G., Webb, C. H., & Hay, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/528690 · Cited by 145
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1313 · Cited by 144
Repeated-Dose Pharmacokinetics of an Oral Solution of Itraconazole in Infants and Children
de Repentigny, L., Ratelle, J., Leclerc, J.-M., Cornu, G., Sokal, E. M., Jacqmin, P., & de Beule, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.404 · Cited by 142 · cited 1×
“peutic concentrations in plasma [66].”
Espinel‐Ingroff, A., Barchiesi, F., Cuenca‐Estrella, M., Pfaller, M. A., Rinaldi, M. G., Rodríguez-Tudela, J. L., & Verweij, P. E. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3884-3889.2005 · Cited by 140
Ophthalmologic, Visceral, and Cardiac Involvement in Neonates with Candidemia
Noyola, D. E., Fernandez, M., Moylett, E. H., & Baker, C. J. (2001) · Clinical Infectious Diseases · doi:10.1086/319601 · Cited by 137 · cited 1×
“In neonates, medical therapy alone, usually with AmB-d, has been most frequently used [216, 217].”
MethodCaspofungin for the treatment of less common forms of invasive candidiasis
Cornely, O. A., Lasso, M., Betts, R. F., Климко, Н. Н., Vázquez, J. A., Dobb, G. J., Vélez, J. D., Williams‐Diaz, A., Lipka, J., Taylor, A., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm169 · Cited by 137
Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
Lange, D., Pavao, J. H., Wu, J., & Klausner, M. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04332.x · Cited by 136
Liposomal amphotericin B treatment for neonatal fungal infections
SCARCELLA, A., PASQUARIELLO, M. B., GIUGLIANO, B., VENDEMMIA, M., & DE LUCIA, A. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199802000-00013 · Cited by 135
Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations
Linder, N. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg419 · Cited by 131
Pappas, P. G., Rotstein, C. M. F., Rf, B., Nucci, M., Talwar, D., Waele, J. J. D., Jm, D. L. V. V., Dupont, B., Horn, D., Ostrosky‐Zeichner, L., et al. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 130
Self-citationPharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
Saxén, H., Hoppu, K., & Pohjavuori, M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.147 · Cited by 127 · cited 1×
“of distribution and longer half-life [63, 64]; it has been recently”
BackgroundThiel, M. A., Zinkernagel, A. S., Burhenne, J., Kaufmann, C., & Haefeli, W. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00762-06 · Cited by 127
A meta-analysis of medical versus surgical therapy for Candida endocarditis
Steinbach, W. J., Perfect, J. R., Cabell, C. H., Fowler, V. G., Corey, G. R., Li, J. S., Zaas, A. K., & Benjamin, D. K. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.10.016 · Cited by 127
Self-citationCartledge, J. D., Midgely, J., & Gazzard, B. G. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.6.477 · Cited by 126
Voriconazole Salvage Treatment of Invasive Candidiasis
Ostrosky-Zeichner, L. L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 125
Self-citationGroll, A. H., Wood, L., Roden, M., Mickiene, D., Chiou, C. C., Townley, E., Dad, L., Piscitelli, S. C., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2554-2563.2002 · Cited by 123
Self-citationViscoli, C., Castagnola, E., Van Lint, M. T., Moroni, C., Garaventa, A., Rossi, M. R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00619-2 · Cited by 122
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120
Self-citationCandidemia in French hospitals: incidence rates and characteristics
Richet, H., Roux, P., de Champs, C., Esnault, Y., & Andremont, A. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00446.x · Cited by 119
Pulmonary Candidiasis in Patients with Cancer: An Autopsy Study
Kontoyiannis, D. P., Reddy, B. T., Torres, H. A., Luna, M. A., Lewis, R. E., Tarrand, J. J., Bodey, G. P., & RAAD, I. I. (2002) · Clinical Infectious Diseases · doi:10.1086/338404 · Cited by 119
Candiduria in Hospital Patients: A Study Prospective
Kobayashi, C. C. B. A., Fernandes, O. D. F. L., Miranda, K. C., de Sousa, E. D., & Silva, M. D. R. R. (2004) · Mycopathologia · doi:10.1023/b:myco.0000038436.51918.d9 · Cited by 117
Bowden, R. A., Cays, M., Gooley, T. A., Mamelok, R. D., & van Burik, J. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1208 · Cited by 117
Philpott‐Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 113
Meningitis Caused by Candida Species: An Emerging Problem in Neurosurgical Patients
Nguyen, M. H., & Yu, V. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.323 · Cited by 112
Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis
Muehrcke, D. D., Lytle, B. W., & Cosgrove, D. M. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00469-2 · Cited by 110
Candida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature
Nguyen, M. H., Nguyen, M. L., Vu, V. L., McMahon, D., Keys, T. F., & Amidi, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.262 · Cited by 109
Echinocandins for Candidemia in Adults without Neutropenia
Bennett, J. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmct060052 · Cited by 109
Walsh, T. J., Whitcomb, P., Piscitelli, S., Figg, W. D., Hill, S., Chanock, S. J., Jarosinski, P., Gupta, R., & Pizzo, P. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1944 · Cited by 109
Self-citationPopulation Pharmacokinetics of Amphotericin B Lipid Complex in Neonates
Würthwein, G., Groll, A. H., Hempel, G., Adler‐Shohet, F. C., Lieberman, J. M., & Walsh, T. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5092-5098.2005 · Cited by 108
Self-citationMalik, I. A., Moid, I., Aziz, Z., Khan, S., & Suleman, M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00326-x · Cited by 106
Schönebeck, J., Polak, A., Fernex, M., & Scholer, H. J. (2009) · Chemotherapy · doi:10.1159/000221279 · Cited by 104
Wilcox, C. M., Darouiche, R. O., Laine, L., Moskovitz, B. L., Mallegol, I., & Wu, J. (1997) · The Journal of Infectious Diseases · doi:10.1086/514028 · Cited by 103
Martins, M. D., Lozano‐Chiu, M., & Rex, J. H. (1998) · Clinical Infectious Diseases · doi:10.1086/515006 · Cited by 103 · cited 1×
“albicans and reduced frequency of symptomatic oropharyngeal candidiasis [272].”
BackgroundSelf-citationEarly diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies
Prella, M., Billé, J., Pugnale, M., Duvoisin, B., Cavassini, M. L., Calandra, T., & Marchetti, O. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.08.015 · Cited by 101
Self-citationCaspofungin in the Treatment of Symptomatic Candiduria
Sobel, J. D., Bradshaw, S. K., Lipka, C. J., & Kartsonis, N. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510432 · Cited by 101
Chronic Candidal Meningitis: An Uncommon Manifestation of Candidiasis
Voice, R. A., Bradley, S., Sangeorzan, J. A., & Kauffman, C. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.1.60 · Cited by 101
Self-citationEchinocandins — An Advance in the Primary Treatment of Invasive Candidiasis
Walsh, T. J. (2002) · New England Journal of Medicine · doi:10.1056/nejme020142 · Cited by 100
Self-citationvon Mach, M.-A., Burhenne, J., & Weilemann, L. S. (2006) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-6-6 · Cited by 99
Use of Fluconazole in the Treatment of Candidal Endophthalmitis
Akler, M. E., Vellend, H., McNeely, D. M., Walmsley, S. L., & Gold, W. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.657 · Cited by 97
Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans.
Marra, F., Robbins, G. M., Masri, B. A., Duncan, C. P., Wasan, K. M., Kwong, E. H., & Jewesson, P. J. (2001) · Europe PMC (PubMed Central) · Cited by 97
Guaraldi, G., Cocchi, S., Codeluppi, M., Benedetto, F. D., Ruvo, N. D., Masetti, M., Venturelli, C., Pecorari, M., Pinna, A. D., & Esposito, R. (2005) · Transplantation · doi:10.1097/01.tp.0000185622.91708.57 · Cited by 96
Pons, V., Greenspan, D., & Debruin, M. (1993) · PubMed · Cited by 94
Juster‐Reicher, A., Leibovitz, E., Linder, N., Amitay, M., Flidel‐Rimon, O., Even-Tov, S., Mogilner, B. M., & Barzilai, A. (2000) · Infection · doi:10.1007/s150100070040 · Cited by 94
Candidal Meningitis in HIV‐Infected Patients: Analysis of 14 Cases
Casado, J. L., Quereda, C., Oliva, J. A., Navas, E., Moreno, A. M., Pintado, V., Cobo, J., & Corral, Í. (1997) · Clinical Infectious Diseases · doi:10.1086/513746 · Cited by 93
Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., Baden, L. R., et al. (2007) · Blood · doi:10.1182/blood.v110.11.163.163 · Cited by 91
Self-citationAntifungal drugs in pregnancy: a review
Moudgal, V. V., & Sobel, J. D. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.5.475 · Cited by 91
Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature
Tunkel, A. R., Thomas, C. Y., & Wispelwey, B. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90127-b · Cited by 90
Phillips, P., Zemcov, J., Mahmood, W., Montaner, J. S. G., Craib, K., & Clarke, A. M. (1996) · AIDS · doi:10.1097/00002030-199610000-00009 · Cited by 88 · cited 1×
“Between 64% and 80% of patients will respond to this therapy [251, 262].”
BackgroundWatson, M. C., Grimshaw, J., Bond, C. M., Mollison, J., & Ludbrook, A. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01142.x · Cited by 87
McQuillen, D. P., Zingman, B. S., Meunier, F., & Levitz, S. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.472 · Cited by 86
Goldman, M. D., Cloud, G. A., Wade, K. D., Reboli, A. C., Fichtenbaum, C. J., Hafner, R., Sobel, J. D., Powderly, W. G., Patterson, T. F., Wheat, L. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497373 · Cited by 83
Self-citationEmphysematous Prostatitis and Cystitis Secondary toCandida Albicans
Bartkowski, D. P., & Lanesky, J. R. (1988) · The Journal of Urology · doi:10.1016/s0022-5347(17)42774-1 · Cited by 81
Flagged first, then by citations
3 of the 305 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,364
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Metadata
- Authors
- Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., Reboli, A. C., Rex, J. H., Walsh, T. J., & Sobe, J. D.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Michigan (US)
- University of Wisconsin–Madison (US)
- Duke Medical Center (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of California, Los Angeles (US)
- Augusta University (US)
- Radboud University Nijmegen (NL)
- University of Texas at Houston, Houston
- Cooper University Hospital (US)
- AstraZeneca (United Kingdom) (GB)
- National Cancer Institute (US)
- Wayne State University (US)
- Corresponding author
- Pappas, Peter G.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-01
- Volume
- 48
- Issue
- 5
- Pages
- 503-535
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7294538
- OpenAlex
- W2150428940
- Cited by
- 3,191
- References
- 305
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 49 · 2023: 55 · 2022: 65 · 2021: 121 · 2020: 155 · 2019: 149 · 2018: 149 · 2017: 195 · 2016: 226 · 2015: 327 · 2014: 312 · 2013: 311 · 2012: 319
- FWCI
- 230.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- reroDoc Digital Library (submittedVersion)
- IRIS (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Amgen
- Pfizer
- AstraZeneca
- Gilead Sciences
- Infectious Diseases Society of America
- Astellas Pharma
- Basilea Pharmaceutica
- National Institutes of Health
- Centers for Disease Control and Prevention
- Pfizer Pharmaceuticals
- National Cancer Institute (Z01SC006830)
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, mucosal candidiasis, candidemia, oropharyngeal candidiasis, esophageal candidiasis, antifungal agents, empirical antifungal therapy, high-risk infants, high-risk adults
- MeSH terms
- Antifungal Agents, Candidiasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
